EGFR c.164T>G ;(p.F55C)

Variant ID: 7-55210054-T-G

NM_005228.3(EGFR):c.164T>G;(p.F55C)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Discovery of a Series of 1,2,3-Triazole-Containing Erlotinib Derivatives With Potent Anti-Tumor Activities Against Non-Small Cell Lung Cancer.

Frontiers In Chemistry
Sun, Ge G; Mao, Longfei L; Deng, Wenjing W; Xu, Shuxiang S; Zhao, Jie J; Yang, Jianxue J; Yao, Kaitai K; Yuan, Miaomiao M; Li, Wei W
Publication Date: 2021

Variant appearance in text: EGFR: F55C
PubMed Link: 35071184
Variant Present in the following documents:
  • Main text
View BVdb publication page



EGFR as a stable marker of prostate cancer dissemination to bones.

British Journal Of Cancer
Nastały, Paulina P; Stoupiec, Sara S; Popęda, Marta M; Smentoch, Julia J; Schlomm, Thorsten T; Morrissey, Colm C; Żaczek, Anna Joanna AJ; Beyer, Burkhard B; Tennstedt, Pierre P; Graefen, Markus M; Eltze, Elke E; Maiuri, Paolo P; Semjonow, Axel A; Pantel, Klaus K; Brandt, Burkhard B; Bednarz-Knoll, Natalia N
Publication Date: 2020-12

Variant appearance in text: EGFR: F55C
PubMed Link: 32901137
Variant Present in the following documents:
  • Main text
View BVdb publication page